Journal News

When things get SAPpy: Novel insights into complement

Lydia Smith
March 20, 2026

The body uses two distinct arms of the immune system to effectively fight off various pathogens, such as bacteria and viruses. The innate immune system is considered the “first responder” and includes the complement system. This system is a key regulator of inflammatory signal amplification and clearance of dead or damaged cells to manage pathogenic infections.

The image shows a structural model of C4BP higher-order structure with multiple C4BP-α (grey).

C4BP is a binding protein responsible for the inactivation of complement protein C4b and, consequently, the complement cascade. Interestingly, C4BP is also known to form higher-order structures, or HOS, allowing C4BP to interact with other complement-related proteins. Recently, Tereza Kadavá and a team of scientists at Utrecht University characterized the interactions of C4BP HOS with two of its known binding partners, C4b and serum amyloid protein, or SAP, and identified potential areas of crosstalk between the two binding interactions. The study was published in Molecular & Cellular Proteomics.

Using a combination of mass photometry and high-speed atomic force microscopy, the team determined that C4b formed three different types of complexes with C4BP HOS particles. The most abundant binding conformation consisted of a 1:1 C4BP:C4b binding ratio, while smaller quantities of complexes were bound in ratios of 1:2 or 1:3. Additionally, they determined that these interactions are specifically mediated by C4BP-α chains within the C4BP structure.

Conversely, SAP showed a strong preference for 1:1 binding ratios, which led to the discovery of SAP pentamer engagement with the entire C4BP HOS. By using cross-linking mass spectrometry, Kadavá and her colleagues discovered that SAP interacts with the C4BP HOS via the C4BP oligomerization core. The researchers also noticed that even in the presence of abundant C4BP-α, C4BP-SAP complex formation did not occur, suggesting that this process is mediated separately from C4BP:C4b binding.

This work provides novel proteomic insights into the complement cascade and structurally defines the C4BP-C4b complex for the first time.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Lydia Smith

Lydia Smith has a B.S. in molecular cell biology and a minor in chemistry, which she received from California State University, Long Beach. She is continuing on to receive her Ph.D. in microbiology and immunology at the University of Utah and is a volunteer contributor for ASBMB Today. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Glutathione pathway implicated in rare disease
Journal News

Glutathione pathway implicated in rare disease

March 19, 2026

Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.

A p-value for proteins
Journal News

A p-value for proteins

March 18, 2026

Kyoto University researchers developed UniScore, a new tool that uses a target-decoy method to filter false positives in proteomic searches, helping scientists set thresholds and improve reliability when analyzing complex protein data.

Novel way to uncover tumor microenvironment proteomics
Journal News

Novel way to uncover tumor microenvironment proteomics

March 17, 2026

Researchers at the Weizmann Institute of Science developed a novel single-cell approach that facilitates the study of proteins surrounding lung cancer cells.

Sizing up cells: How stem cells know when to divide
News

Sizing up cells: How stem cells know when to divide

March 12, 2026

Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.

When oncogenes collide in brain development
Journal News

When oncogenes collide in brain development

March 10, 2026

Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.